Heterodimeric antibody Fc-containing proteins and methods for production thereof

TIGIT antibody, antigen-binding fragment thereof, and medical use thereof

Antibody variants

NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A

Antibody-drug conjugates and uses thereof

ANTIBODY-DRUG CONJUGATE LYOPHILISED FORMULATION

Systems and methods for miniaturized antenna for wireless power transmissions

Antibodies to TIP1 and methods of use thereof

PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-BST-1 ANTIBODY AND A CYTIDINE ANALOGUE

CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT

Anti-c-Met antibody and use thereof

Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders

BINDING PROTEINS 2

Binding proteins 1

Tumor selective macropinocytosis-dependent rapidly internalizing antibodies

Antibody variants

MACROPINOCYTOSING HUMAN ANTI-CD46 ANTIBODIES AND TARGETED CANCER THERAPEUTICS

KIR3DL2 binding agents

Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies

Antigen binding proteins

BAFF-R antibodies and uses thereof

Diagnosis and treatment of cancer

COMPOSITIONS COMPRISING RESURFACED CELL-PENETRATING NANOBODIES AND METHODS OF USE THEREOF

Nanoparticle platform for antibody and vaccine delivery

Bispecific binding proteins and uses thereof

Methods of neutralizing IL-8 biological activity

Anti-CDH6 antibody and method of producing an anti-CDH6 antibody-drug conjugate

Methods and compositions for generation of binding agents against cell surface antigens

Anti-CLL-1 antibodies and methods of use

TREM2 stabilizing antibodies

Antibodies that bind cell surface GRP78

Light chain variable regions

Therapeutic molecules binding PSMA

Anti-TREM1 antibodies and methods of use thereof

METHODS FOR DNA-DEPENDENT TARGETING OF A CELL PERMEANT ANTIBODY

ANTIBODY DRUG CONJUGATES

Anti-TMEFF1 antibodies and antibody drug conjugates

Methods of preparing a re-usable single cell and methods for analyzing the epigenome, transcriptome, and genome of a single cell

Anti-CEACAM5 antibodies and uses thereof

Engineered immunoglobulin Fc polypeptides displaying improved complement activation

Immunoparticles and methods of generating and using same

POLYPEPTIDE VACCINE

Methods of making multispecific antigen-binding molecules

Photosensitizing antibody-fluorophore conjugates

Tumor targeted radionuclide therapy and molecular imaging of HER2+ cancers and other neoplasms

Antibody-drug conjugates and uses thereof

Photosensitizing antibody-fluorophore conjugates

Binding molecules specific for CD73 and uses thereof

Isoform-selective TGFβ1 inhibitors and use thereof

Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic properties

T CELL RECEPTOR LIKE ANTIBODIES

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

Internalizing human monoclonal antibodies targeting prostate and other cancer cells

COMPOSITIONS AND METHODS FOR NON-MYELOABLATIVE CONDITIONING

ANTI-HLA-DQ2.5/8 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC DISEASE

Methods for DNA-dependent targeting of a cell permeant antibody

METHOD OF STIMULATING ASYMMETRIC DIVISION OF SATELLITE STEM CELLS

Fusion proteins (Seldegs) for selectively depleting antigen-specific antibodies and methods of use thereof

Monoclonal antibodies against HER2 epitope and methods of use thereof

Anti-ILT3 antibodies and antibody drug conjugates

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates

Anti oligosaccharide antibody

Compositions comprising R-Spondin (RSPO) surrogate molecules

Anti-NRP1 antibody screening method

Methods to manipulate alpha-fetoprotein (AFP)

Active targeting of cells by monosized protocells

ErbB2 antibodies and uses therefore

Binding molecules specific for FcγRIIA and uses thereof

HUMANIZED ANTIBODIES THAT BIND LGR5

Monoclonal antibodies to human FLT3/FLK2 receptor protein

Selective reduction of cysteine-engineered antibodies

Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

Site-specific conjugation of linker drugs to antibodies and resulting ADCS

Site-specific conjugation of linker drugs to antibodies and resulting ADCS

Monoclonal antibodies specific to the plexin-semaphorin-integrin (PSI) domain of RON for drug delivery and its application in cancer therapy

ANTIBODY SPECIFIC FOR CD22 AND METHODS OF USE THEREOF

Anti-sclerostin antibodies and methods of use

Phage conjugates and uses thereof

Engineered antibodies and uses thereof

Anti-FGFR3 antibodies and methods using same

CMET monoclonal binding agents, drug conjugates thereof and uses thereof

IGF-1R antibody and its use as addressing vehicle for the treatment of cancer

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

Antibodies to bone marrow stromal antigen 1

Bispecific antibodies specific for PD1 and TIM3

Methods and compositions for treatment of Lafora disease

HUMAN MONOCLONAL ANTIBODIES TO FUCOSYL-GM1 AND METHODS FOR USING ANTI-FUCOSYL-GM1 ANTIBODIES

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

Treatment of disease responsive to modulation of cannabanoid 1(CB1) receptor signaling

MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF

CELL PENETRATING NUCLEOLYTIC ANTIBODY BASED CANCER THERAPY

J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (PSMA) and methods for their use

Internalizing moieties

Binding molecules specific for CD73 and uses thereof

Anti-KRAS binding proteins

Anti-CD46 antibodies and methods of use

Anti-Tim-3 antibodies and use thereof

Anti-SIRP-alpha antibodies and methods of use thereof

Antibodies binding AXL

Antibodies to CD70

Process for the preparation of an antibody-rifamycin conjugate

Antibodies directed to HER-3 and uses thereof

BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof

Antibody constructs for DLL3 and CD3

Recombinant antibody and uses thereof

Anti-CD73 antibodies and uses thereof

CD33 BINDING AGENTS

Combination of ABCG2 inhibitors with sacituzumab govitecan (IMMU-132) overcomes resistance to SN-38 in Trop-2 expressing cancers

Anti-CLL-1 antibodies and immunoconjugates

Methods of treating cardiovascular disease with an anti-ASGR antibody or binding fragments thereof

DLL3 MODULATORS AND METHODS OF USE

Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells

Anti-B7-H4 antibodies and immunoconjugates

Conjugates comprising an anti-EGFR1 antibody

Method for screening antibody using patient-derived tumor spheroids

Anti-GPR20 antibody and anti-GPR20 antibody-drug conjugate

Targeted Therapeutic Proteins

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates

Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1

TRPM4 CHANNEL INHIBITORS FOR STROKE TREATMENT

Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof

EphA5-binding antibodies and uses thereof and selection of phage-displayed accessible recombinant targeted antibodies

EGFR binding molecules

Antigen binding protein against HER3

ANTI-SAS1B ANTIBODIES, ASSOCIATED METHODS OF USE, AND COMPOSITIONS AND METHODS FOR DETECTING AND TREATING CANCER

Anti-TEM1 antibodies and uses thereof

Anti-Siglec-7 antibodies for the treatment of cancer

Chimeric proteins for targeting dsRNA

Antibody targeted to tissue factor, preparation method therefor, and use thereof

Anti-Axl antagonistic antibodies

Anti-annexin A2 monoclonal antibodies

RECOMBINANT MONOVALENT ANTIBODIES AND METHODS FOR PRODUCTION THEREOF

Endosialin-binding antibody

Antibodies binding AXL

Anti-CD40 antibodies for use in treatment of Sjögren's syndrome

Anti-BMPR1B antibodies and methods of use

Anti-ROR1 antibodies

Anti-HER3 antibody-drug conjugate

Cytosol-penetrating antibody and use thereof

Anti-TROP2 antibody-drug conjugate

Compositions and methods for the depletion of CD117+ cells

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

B7-H3 binding molecules, antibody drug conjugates thereof and methods of use thereof

Method of eliminating hematopoietic stem cells/hematopoietic progenitors (HSC/HP) in a patient using bi-specific antibodies

Plectin-1 binding antibodies and uses thereof

Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibody

FULLY HUMAN ANTIBODIES TO BTLA

Antibody drug conjugates

Method for treating breast cancer

COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES

Human antibodies to Tn antigen

Methods of treating by administering anti-kit antibodies

CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER

Antibody-drug conjugates and immunotoxins

Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins

ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE

Anti-huLRRC15 antibody drug conjugates and methods for their use

Nanobody dimers linked via C-terminally engineered cysteins

Methods of treating by administering anti-kit antibodies

ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE

T-CELL RECEPTOR MIMIC (TCRM) ANTIBODIES

NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 161P2F10B USEFUL IN TREATMENT AND DETECTION OF CANCER

Antigen responsive antibody-fluorescent dye conjugate and method for fluorescence detection and imaging of target cell using the same

Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof

Efficacy of anti-HLA-DR antibody drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers

Conjugates enhancing total cellular accumulation

NOVEL ANTI-CLAUDIN ANTIBODIES AND METHODS OF USE

Fc variants with increased affinity for FcγRIIc

Antibody-drug conjugates and uses thereof

Antibodies against CD73 and uses thereof

Anti-B7-H4 antibodies and immunoconjugates

Anti-Siglec-9 antibodies and methods of use thereof

TM4SF1 binding proteins and methods of using same

ANTIBODIES AGAINST CD73 AND USES THEREOF

IGF-1R antibody and its use for the diagnosis of cancer

REDIRECTING IMMUNE RESPONSES

SYNERGISTIC ANTI-CD47 THERAPY FOR HEMATOLOGIC CANCERS

DLL3 MODULATORS AND METHODS OF USE

Cadherin-17 specific antibodies and cytotoxic cells for cancer treatment

BCMA monoclonal antibody-drug conjugate

Immunoconjugate and uses thereof

Binding molecules specific for HER3 and uses thereof

Anti-CD33 antibodies and methods of use thereof

Methods for delivering cargo into a cell by using signal molecules as cell penetration agents

Molecules that bind prostate specific membrane antigen (PSMA)

Biological materials related to HER3

NOVEL SEZ6 MODULATORS AND METHODS OF USE

Self-crosslinking antibodies

Anti-CD43 antibody and use thereof for cancer treatment

Antibody constructs for CDH19 and CD3

Antibodies binding LAG-3 and uses thereof

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Therapeutic antibodies and uses thereof

Antibody-drug conjugate

Anti-myostatin antibodies and methods of use

Multispecific antigen-binding molecules and uses thereof

Anti-Axl antibodies

LGR4 specific monoclonal antibodies and methods of their use

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates

Anti-GCC antibody molecules and related compositions and methods

SIRP alpha-antibody fusion proteins

Method of detection of IL1RAP on cells expressing the protein

Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof

Compositions and methods for internalizing enzymes

Therapeutic antibodies against ROR-1 protein and methods for use of same

Human monoclonal antibodies to ganglioside GD2

Chimeric proteins for targeting dsRNA

HUMANIZED PAN-HER ANTIBODY COMPOSITIONS

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)

Antibodies comprising modified heavy constant regions

Glycan-interacting compounds and methods of use

NOVEL ANTI-EMR2 ANTIBODIES AND METHODS OF USE

COMPOSITIONS AND METHODS FOR TREATING CANCER

CD19 binding agents and uses thereof

Bi-specific antibodies for enhanced tumor selectivity and inhibition and uses thereof

Bispecific antibodies specifically binding to PD1 and LAG3

Anti-DLL3 antibody drug conjugates for treating cancer

Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)

ANTI-GPC3 ANTIBODIES AND IMMUNOCONJUGATES

Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses

Anti-EGFRvIII antibodies and uses thereof

Anti-CD33 antibodies and immunoconjugates

Nucleic acid encoding dual Fc antigen binding proteins

Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)

Anti-TPBG antibodies and methods of use

Vaccines against antigens involved in therapy resistance and methods of using same

GLYCOENGINEERED BINDING PROTEIN COMPOSITIONS

ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES

CELL-TARGETING MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL, SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS

ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TWO OR MORE ANTIGEN MOLECULES REPEATEDLY

Antigen-binding molecule capable of binding two or more antigen molecules repeatedly

ANTI-TFPI ANTIBODY VARIANTS WITH DIFFERENTIAL BINDING ACROSS PH RANGE FOR IMPROVED PHARMACOKINETICS

Bispecific antigen-binding constructs targeting Her2

Antigen-binding constructs targeting HER2

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

Binding molecules specific for ASCT2 and uses thereof

Anti-MUC18 human immunotoxin and applications thereof

Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab govitecan (IMMU-132) overcomes homologous recombination repair (HRR) rescue mediated by Rad51

Humanized anti-TF-antigen antibodies

ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF

Anti-CD115 antibodies

Nucleic acids encoding IL-8 antibodies

CYTOTOXIC PROTEINS COMPRISING CELL-TARGETING BINDING REGIONS AND SHIGA TOXIN A SUBUNIT REGIONS FOR SELECTIVE KILLING OF SPECIFIC CELL TYPES

METHODS AND COMPOSITIONS FOR TREATMENT OF POMPE DISEASE

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

HIGH-Z NANOPARTICLES AND THE USE THEREOF IN RADIATION THERAPY

Humanized anti-CCR7 receptor antibodies

NOVEL MODULATORS AND METHODS OF USE

Sialyl-di-Lewisas expressed on glycoproteins but not glycolipids as a functional cancer target and antibodies thereto

Cell penetrating protein-antibody conjugates and methods of use

Antibodies to MUC16 and methods of use thereof

Monoclonal antibodies against HER2

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

Antibodies binding AXL

COMBINATIONS OF EPIDERMAL GROWTH FACTOR RECEPTOR TARGETING ANTIBODIES FOR TREATING CANCER

OPTIMIZED Fc VARIANTS

Antibodies targeting CDH19 for melanoma

Anti-NKP46 antibodies, toxin conjugates, and therapeutic use of same

THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTS

Binding molecules specific for CD73 and uses thereof

Monoclonal antibodies against HER2

Eribulin-based antibody-drug conjugates and methods of use

Drug-conjugated bi-specific antigen-binding constructs

CKIT antibody drug conjugates

Antibodies targeting B-cell receptor complex membrane bound IgM and uses thereof

Anti-VEGFR antibody and uses thereof

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITORS WITH ANTI-B7H3-ANTIBODIES

Methods of treating PRLR positive breast cancer

Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug conjugate (ADC) targeting Trop-2

Bispecific antigen-binding constructs targeting HER2

MONOCLONAL ANTIBODIES AGAINST HER2

Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies

ANTI-5T4 ANTIBODIES AND USES THEREOF

Compositions and methods to enhance the immune system

MULTIVALENT MEDITOPES, MEDITOPE-BINDING ANTIBODIES AND USES THEREOF

OPTIMIZED ANTIBODIES THAT TARGET CD19

ANTIGEN BINDING PROTEINS

ANTI-LAMP1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES, AND USES THEREOF

Anti-ROR1 antibodies

Antibodies reactive with B7-H3 and users thereof

Antibodies against CD73 and uses thereof

ANTIBODY DRUG CONJUGATES

Therapeutic combinations comprising anti-CD73 antibodies and uses thereof

Disease therapy by inducing immune response to Trop-2 expressing cells

Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4

Sensor systems for target ligands and uses thereof

Drug conjugates comprising antibodies against claudin 18.2

Anti-MUC16 antibodies and uses thereof

Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof

Immune conjugate having dendron conjugated to antibody and use thereof

Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)